Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Ajanta Pharma's promoter, Ravi Agrawal Trust, offloaded 34.50 lakh equity shares, amounting to a 2.76% stake reduction. The shares were sold through an open market transaction on June 9, 2026.
Jun 09 2026 15:41:34
Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Ajanta Pharma's promoter, Aayush Agrawal (Trustee Aayush Agrawal Trust), has pledged 28.55 lakh shares, equating to 2.29% of the company's total share capital. This action was undertaken to secure a new loan.
Jun 09 2026 10:22:41
Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Ajanta Pharma's promoter, Gabs Investments Pvt. Ltd., has created a pledge on 27.70 lakh shares, which is 2.22% of the company's total share capital. The pledge was created to secure a new loan.
Jun 09 2026 10:21:24
Ajanta Pharma Ltd - 532331 - Participation In Investor Conference
Ajanta Pharma has scheduled two analyst/institutional investor meetings. The first is with ICICI Securities India on May 29, 2026, and the second is with 360 ONE Capital on June 8, 2026, to discuss already published information.
May 19 2026 15:40:13
Read More